Thomas R Keeble
CORE 2021 – On-demand
Published: 16 June 2021
-
Views:
71081
-
Likes:
7
Overview
Full programme
The Role of an “Optimising” Procedure in Complex PCI
Overview
The 5th annual CORE meeting (16 and 17 June 2021) was hosted by Radcliffe Cardiology in collaboration with Optima Education and Abbott Vascular.
The meeting was led by Course Directors Prof Adrian Banning, Prof Evald Christiansen, Dr Jonathan Hill and Prof James Spratt and streamed from our London, Copenhagen, and Dublin hubs.
CORE 2021 focuses on contemporary standards of clinical practice, complex lesion and patient strategies and advanced diagnostic and treatment methods. The goal of CORE is to ensure procedural efficiencies while achieving durable patient outcomes, review patient care beyond intervention and discuss the best practices and innovation outside the catheterisation lab.
CORE 2021 is brought to you by Optima Education, Abbott, and Radcliffe Cardiology
More from this programme
-
Welcome and Angina as a Therapeutic Goal – Redefining Success
-
Treating Angina: How to Leverage the Placebo Effect!
-
The MDT Discussion – Defining Standards
-
LIVE CASES: MVD Case Physiology - Defining Target Lesion, Bystander Disease, and INOCA Patient - How to Perform Full Physiology
-
Myocardial Bridge – Physiology and Guide to Assessment and Treatment and Morning Summary
-
Welcome and EBC Updates on Left Main
-
The DK Crush - Optimised
-
LIVE CASES: Calcified Left Main Bifurcation Case and OCT Guided Bifurcation Treatment
-
Culotte – Optimised
-
Recognising and Troubleshooting Bifurcation Complications
-
CORE 2021 - Day 1 Wrap-up
Faculty biographies
Darren Mylotte
Consultant Cardiologist
Dr Mylotte graduated from RCSI Medical School in 2001, obtained membership of the Royal College of Physicians in Ireland in 2004, and completed the Irish Cardiology Specialist Training Scheme. He and was conferred with a Doctor of Medicine (MD) thesis in 2010 by the Royal College of Surgeons in Ireland and has also undertaken a PhD thesis. N the subject of Transcatheter Aortic Valve Implantation (TAVI) at the world renowned ThoraxCentre in Rotterdam, The Netherlands. Dr Mylotte undertook a two-year clinical interventional cardiology fellowship at the acclaimed Institut Cardiovasculaire de Paris, in Massy, France. He also performed a further two-year advanced fellowship in congenital and structural heart disease at McGill University, Montreal, Canada.
Dr Mylotte specializes in general cardiology, and has subspecialty interests in the assessment, diagnosis and treatment of ischaemic heart disease, valvular heart disease
